Israeli Placenta-based Cell Therapy for COVID-19 Moved into Clinical Trial
As originally shared in Tech Startups, an Israeli biotech company called Pluristem has created a placenta-based cell therapy to treat patients with COVID-19. So far, the therapy, which uses PLacental…